Kali, Inc. (KALY)
Kali, Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Dallas, TX, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $101,824. On trailing twelve-month figures it carries a trailing P/E of -8.55, a net margin of -18.2%. Its beta of -72.35 implies it has historically moved less than the broad market.
Kali, Inc., which conducts business as Kali-Extracts, Inc., focuses its efforts on the research and development of cannabis-based treatments. The company aims to address a variety of medical conditions, including various illnesses, diseases, and the persistent pain that can accompany diverse diagnoses. Its offerings encompass a range of products, including pharmaceutical preparations, cannabis extracts, and general health and wellness items. The entity was formerly identified as VLOV Inc. until it adopted the name Kali, Inc. in February 2016. Kali, Inc. is headquartered in Dallas, Texas.
Kali, Inc. is most often compared with the following Healthcare names: